Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.29 billion.
Market Cap
1.11T
Revenue
105.29B
Profits
-41.72B
PE Ratio
n/a
Profit Margin
-39.62%
Dividend Yield
0.04%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.92B | -0.38% | 15,930 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.37B | 0.65% | 19,812 | 14.25B |
| 3 | ARGX | argenx SE | 49.64B | 0.08% | 5,708 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 48.91B | 0.07% | 10,674 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 37.98B | -2.22% | 20,915 | 4.97B |
| 6 | INSM | Insmed Incorporated | 34.66B | -0.74% | 56,002 | 447.02M |
| 7 | BNTX | BioNTech SE | 27.27B | 1.37% | 65,461 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.29B | -0.02% | 69,588 | 2.35B |
| 9 | RVMD | Revolution Medicines, Inc. | 23.16B | -0.12% | 48,278 | - |
| 10 | GMAB | Genmab A/S | 20.59B | 2.95% | 279,407 | 3.85B |
| 11 | INCY | Incyte Corporation | 20.31B | - | 38,626 | 4.81B |
| 12 | ROIV | Roivant Sciences Ltd. | 16.29B | -0.09% | 146,273 | 20.33M |
| 13 | MRNA | Moderna, Inc. | 15.93B | 2.95% | 1,231,296 | 2.23B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 15.22B | -0.15% | 55,986 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 13.18B | -0.14% | 13,530 | 758.59M |
| 16 | SMMT | Summit Therapeutics Inc. | 13.04B | 0.59% | 46,497 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.83B | -0.36% | 12,596 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 12.05B | 1.59% | 39,532 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.17B | -0.39% | 3,577 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.91B | -0.05% | 24,039 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.78B | 1.63% | 52,883 | 3.09B |
| 22 | TECH | Bio-Techne Corporation | 10.43B | 0.84% | 24,104 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 9.92B | 0.46% | 901 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.42B | 3.18% | 245,811 | 6.23M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.95B | -0.60% | 48,384 | 829.45M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.79B | - | 348 | 561.26M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 8.44B | 0.18% | 19,658 | 1.24B |
| 28 | KRYS | Krystal Biotech, Inc. | 8.44B | -0.28% | 511,983 | 373.16M |
| 29 | NUVL | Nuvalent, Inc. | 7.86B | - | 431 | - |
| 30 | CYTK | Cytokinetics, Incorporated | 7.71B | -0.39% | 21,035 | 87.21M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 7.70B | - | 25 | 7.46M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.45B | 0.04% | 58,054 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.21B | 0.17% | 15,645 | 174.33M |
| 34 | PCVX | Vaxcyte, Inc. | 6.02B | - | 103 | - |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.02B | -0.56% | 48,164 | 1.78B |
| 36 | KYMR | Kymera Therapeutics, Inc. | 5.93B | - | 103 | 43.74M |
| 37 | BLTE | Belite Bio, Inc | 5.89B | - | - | - |
| 38 | COGT | Cogent Biosciences, Inc. | 5.55B | 3.46% | 44,364 | - |
| 39 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.55B | -0.39% | 20,073 | 1.54M |
| 40 | GPCR | Structure Therapeutics Inc. | 5.45B | 1.24% | 49,822 | - |
| 41 | CRSP | CRISPR Therapeutics AG | 5.39B | 0.69% | 59,033 | 38.34M |
| 42 | APGE | Apogee Therapeutics, Inc. | 5.33B | - | 20 | - |
| 43 | IMVT | Immunovant, Inc. | 5.29B | -0.31% | 16,238 | - |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 5.12B | 0.69% | 10,265 | 209.22M |
| 45 | CELC | Celcuity Inc. | 4.94B | 2.39% | 9,343 | - |
| 46 | TGTX | TG Therapeutics, Inc. | 4.78B | 17.33% | 1,063,764 | 531.90M |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 4.67B | -0.18% | 1,209 | 471.79M |
| 48 | ACAD | ACADIA Pharmaceuticals Inc. | 4.50B | 0.42% | 30,090 | 1.05B |
| 49 | SRRK | Scholar Rock Holding Corporation | 4.49B | 0.59% | 33,054 | - |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.43B | - | 33,130 | 598.70M |
| 51 | CGON | CG Oncology, Inc. | 4.24B | - | 197 | 2.17M |
| 52 | ADMA | ADMA Biologics, Inc. | 4.21B | - | 20,014 | 488.56M |
| 53 | LEGN | Legend Biotech Corporation | 4.16B | -0.29% | 53,690 | 909.05M |
| 54 | ACLX | Arcellx, Inc. | 3.86B | - | 5,221 | 35.90M |
| 55 | CORT | Corcept Therapeutics Incorporated | 3.82B | -0.08% | 11,082 | 741.17M |
| 56 | TERN | Terns Pharmaceuticals, Inc. | 3.80B | 1.34% | 28,651 | - |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 3.73B | 0.33% | 437 | 251.23M |
| 58 | NAMS | NewAmsterdam Pharma Company N.V. | 3.61B | -0.19% | 6,968 | 35.24M |
| 59 | VKTX | Viking Therapeutics, Inc. | 3.52B | 1.53% | 97,567 | - |
| 60 | BEAM | Beam Therapeutics Inc. | 3.52B | 3.21% | 107,427 | 55.70M |
| 61 | VERA | Vera Therapeutics, Inc. | 3.48B | -0.18% | 12,400 | - |
| 62 | LQDA | Liquidia Corporation | 3.33B | 0.39% | 91,806 | 69.22M |
| 63 | CNTA | Centessa Pharmaceuticals plc | 3.25B | - | 15 | 15.00M |
| 64 | TARS | Tarsus Pharmaceuticals, Inc. | 3.21B | - | 3,000 | 366.10M |
| 65 | ARQT | Arcutis Biotherapeutics, Inc. | 3.18B | -0.19% | 46,099 | 317.93M |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.13B | 0.40% | 19,137 | 7.50M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.08B | 0.06% | 7,057 | 214.83M |
| 68 | VRDN | Viridian Therapeutics, Inc. | 3.06B | 0.11% | 6,492 | 70.79M |
| 69 | IBRX | ImmunityBio, Inc. | 2.94B | 5.67% | 6,461,746 | 82.56M |
| 70 | IRON | Disc Medicine, Inc. | 2.85B | 0.21% | 1,640 | - |
| 71 | DNLI | Denali Therapeutics Inc. | 2.83B | - | 963 | - |
| 72 | RCUS | Arcus Biosciences, Inc. | 2.82B | 0.22% | 30,656 | 240.00M |
| 73 | ALMS | Alumis Inc. | 2.82B | 2.22% | 126,295 | 22.12M |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.80B | -0.23% | 138,448 | - |
| 75 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.77B | 0.81% | 74,213 | 578.20M |
| 76 | ADPT | Adaptive Biotechnologies Corporation | 2.75B | -0.28% | 30,889 | 252.75M |
| 77 | EWTX | Edgewise Therapeutics, Inc. | 2.70B | 2.12% | 9,918 | - |
| 78 | APLS | Apellis Pharmaceuticals, Inc. | 2.65B | -1.78% | 56,232 | 1.02B |
| 79 | WVE | Wave Life Sciences Ltd. | 2.64B | 1.62% | 96,098 | 109.23M |
| 80 | MLYS | Mineralys Therapeutics, Inc. | 2.60B | -0.43% | 27,368 | - |
| 81 | AAPG | Ascentage Pharma Group International | 2.57B | -1.04% | 57 | 54.52M |
| 82 | TLX | Telix Pharmaceuticals Limited | 2.51B | 1.06% | 1,492 | 664.23M |
| 83 | TVTX | Travere Therapeutics, Inc. | 2.50B | -3.85% | 236,465 | 435.83M |
| 84 | RXRX | Recursion Pharmaceuticals, Inc. | 2.46B | 0.75% | 1,510,000 | 43.69M |
| 85 | SYRE | Spyre Therapeutics, Inc. | 2.44B | -0.13% | 8,070 | - |
| 86 | RARE | Ultragenyx Pharmaceutical Inc. | 2.30B | -0.95% | 25,514 | 630.60M |
| 87 | MESO | Mesoblast Limited | 2.30B | -0.34% | 8,680 | 17.20M |
| 88 | SRPT | Sarepta Therapeutics, Inc. | 2.29B | 1.72% | 96,808 | 2.41B |
| 89 | NUVB | Nuvation Bio Inc. | 2.27B | 0.92% | 376,016 | 26.75M |
| 90 | IMNM | Immunome, Inc. | 2.26B | 1.89% | 15,688 | 9.68M |
| 91 | SLNO | Soleno Therapeutics, Inc. | 2.24B | 0.55% | 15,817 | 98.68M |
| 92 | OCUL | Ocular Therapeutix, Inc. | 2.24B | 0.67% | 71,062 | 55.78M |
| 93 | OLMA | Olema Pharmaceuticals, Inc. | 2.23B | 1.61% | 52,548 | - |
| 94 | GLPG | Galapagos NV | 2.19B | 0.27% | 7,789 | 336.64M |
| 95 | ERAS | Erasca, Inc. | 2.18B | 2.20% | 398,276 | - |
| 96 | ZLAB | Zai Lab Limited | 2.17B | 4.17% | 47,242 | 441.63M |
| 97 | HRMY | Harmony Biosciences Holdings, Inc. | 2.05B | -0.34% | 268 | 825.94M |
| 98 | MAZE | Maze Therapeutics, Inc. | 1.99B | - | 10 | 2.50M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -0.47% | 1,158,101 | 265.81M |
| 100 | DNTH | Dianthus Therapeutics, Inc. | 1.96B | 1.72% | 895 | 3.08M |
| 101 | NRIX | Nurix Therapeutics, Inc. | 1.91B | -0.26% | 763 | 83.69M |
| 102 | GLUE | Monte Rosa Therapeutics, Inc. | 1.86B | -2.04% | 48,216 | 181.54M |
| 103 | VCEL | Vericel Corporation | 1.84B | -1.73% | 17,115 | 258.72M |
| 104 | SNDX | Syndax Pharmaceuticals, Inc. | 1.80B | 1.22% | 18,291 | 111.30M |
| 105 | ZYME | Zymeworks Inc. | 1.77B | -1.21% | 4,716 | 134.48M |
| 106 | UPB | Upstream Bio, Inc. | 1.76B | -0.18% | 834,699 | 2.80M |
| 107 | KOD | Kodiak Sciences Inc. | 1.75B | -0.25% | 19,613 | - |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.73B | -1.01% | 15,458 | 205.63M |
| 109 | MNKD | MannKind Corporation | 1.72B | -0.71% | 46,235 | 313.79M |
| 110 | CLDX | Celldex Therapeutics, Inc. | 1.72B | -0.44% | 9,112 | 2.60M |
| 111 | ARDX | Ardelyx, Inc. | 1.71B | 0.14% | 179,168 | 398.23M |
| 112 | PHVS | Pharvaris N.V. | 1.69B | - | 52 | - |
| 113 | IMCR | Immunocore Holdings plc | 1.66B | 1.55% | 6,538 | 379.59M |
| 114 | SION | Sionna Therapeutics, Inc. | 1.64B | - | 96 | - |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 1.64B | 1.26% | 20,178 | 44.79M |
| 116 | MBX | MBX Biosciences, Inc. | 1.63B | 0.14% | 669 | - |
| 117 | FTRE | Fortrea Holdings Inc. | 1.61B | 0.29% | 22,605 | 2.76B |
| 118 | NBY | NovaBay Pharmaceuticals, Inc. | 1.56B | -4.91% | 121,541 | 10.30M |
| 119 | TYRA | Tyra Biosciences, Inc. | 1.55B | 0.62% | 1,999 | - |
| 120 | ORKA | Oruka Therapeutics, Inc. | 1.53B | 1.15% | 6,163 | - |
| 121 | ELVN | Enliven Therapeutics, Inc. | 1.51B | -1.05% | 7,596 | - |
| 122 | PGEN | Precigen, Inc. | 1.48B | 0.24% | 48,355 | 6.31M |
| 123 | INVA | Innoviva, Inc. | 1.47B | 0.97% | 12,719 | 388.52M |
| 124 | MNMD | Mind Medicine (MindMed) Inc. | 1.46B | - | 57,760 | - |
| 125 | TRVI | Trevi Therapeutics, Inc. | 1.44B | -0.80% | 7,505 | - |
| 126 | BHVN | Biohaven Ltd. | 1.43B | -1.55% | 98,092 | - |
| 127 | SVRA | Savara Inc. | 1.43B | - | 6 | - |
| 128 | TNGX | Tango Therapeutics, Inc. | 1.42B | 1.25% | 493 | 66.50M |
| 129 | RLAY | Relay Therapeutics, Inc. | 1.40B | 1.89% | 23,895 | 8.36M |
| 130 | NTLA | Intellia Therapeutics, Inc. | 1.39B | 2.39% | 538,909 | 57.53M |
| 131 | NVAX | Novavax, Inc. | 1.36B | -3.58% | 406,704 | 1.06B |
| 132 | TSHA | Taysha Gene Therapies, Inc. | 1.36B | 1.12% | 269,347 | 6.31M |
| 133 | ATAI | AtaiBeckley Inc. | 1.34B | 0.82% | 102,512 | 3.02M |
| 134 | OCS | Oculis Holding AG | 1.34B | 0.54% | 8,169 | 992.00K |
| 135 | ANAB | AnaptysBio, Inc. | 1.33B | 0.16% | 5,568 | 169.47M |
| 136 | EYPT | EyePoint, Inc. | 1.33B | 0.75% | 43,243 | 42.34M |
| 137 | QURE | uniQure N.V. | 1.32B | -1.63% | 39,418 | 15.75M |
| 138 | RAPP | Rapport Therapeutics, Inc. | 1.29B | - | 1 | - |
| 139 | SANA | Sana Biotechnology, Inc. | 1.28B | 1.91% | 115,946 | - |
| 140 | CAPR | Capricor Therapeutics, Inc. | 1.27B | -0.73% | 23,298 | 11.13M |
| 141 | ABCL | AbCellera Biologics Inc. | 1.27B | -0.94% | 282,351 | 35.33M |
| 142 | IMTX | Immatics N.V. | 1.26B | - | 2,927 | 99.45M |
| 143 | XERS | Xeris Biopharma Holdings, Inc. | 1.25B | -2.08% | 44,226 | 266.14M |
| 144 | MLTX | MoonLake Immunotherapeutics | 1.23B | 1.05% | 75,348 | - |
| 145 | PVLA | Palvella Therapeutics, Inc. | 1.23B | - | 6 | - |
| 146 | PHAR | Pharming Group N.V. | 1.22B | -0.55% | 1 | 362.27M |
| 147 | PHAT | Phathom Pharmaceuticals, Inc. | 1.21B | -0.96% | 49,813 | 147.19M |
| 148 | SEPN | Septerna, Inc. | 1.17B | -0.57% | 675 | 22.05M |
| 149 | ZBIO | Zenas BioPharma, Inc. | 1.14B | -1.72% | 68,664 | 15.00M |
| 150 | AKTS | Aktis Oncology, Inc. | 1.12B | -0.23% | 4,256 | 5.56M |
| 151 | SPRY | ARS Pharmaceuticals, Inc. | 1.11B | -0.97% | 2,959 | 142.77M |
| 152 | IVA | Inventiva S.A. | 1.09B | 2.45% | 47,289 | 19.93M |
| 153 | DAWN | Day One Biopharmaceuticals, Inc. | 1.06B | -2.74% | 78,599 | 133.67M |
| 154 | INBX | Inhibrx Biosciences, Inc. | 1.04B | -2.61% | 19,175 | 1.40M |
| 155 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.03B | 0.25% | 19,303 | 192.44M |
| 156 | TBPH | Theravance Biopharma, Inc. | 1.03B | - | 2 | 80.33M |
| 157 | ORIC | ORIC Pharmaceuticals, Inc. | 1.02B | 3.45% | 51,067 | - |
| 158 | NBTX | Nanobiotix S.A. | 1.02B | -0.89% | 5,766 | 11.93M |
| 159 | XNCR | Xencor, Inc. | 995.46M | - | 160 | 150.13M |
| 160 | VTYX | Ventyx Biosciences, Inc. | 993.02M | -0.14% | 37,665 | - |
| 161 | GHRS | GH Research PLC | 982.55M | - | 8,012 | - |
| 162 | CMPX | Compass Therapeutics, Inc. | 981.80M | -1.08% | 38,653 | 850.00K |
| 163 | BCAX | Bicara Therapeutics Inc. | 964.16M | 0.40% | 538 | - |
| 164 | RAPT | RAPT Therapeutics, Inc. | 945.22M | 0.15% | 50 | - |
| 165 | IOVA | Iovance Biotherapeutics, Inc. | 940.81M | 0.85% | 272,827 | 250.43M |
| 166 | URGN | UroGen Pharma Ltd. | 923.54M | -0.50% | 73,991 | 96.52M |
| 167 | ANNX | Annexon, Inc. | 921.17M | -0.16% | 114,033 | - |
| 168 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 920.67M | - | 13 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 911.62M | - | 15,800 | 14.61M |
| 170 | AVBP | ArriVent BioPharma, Inc. | 906.95M | - | 106 | - |
| 171 | VIR | Vir Biotechnology, Inc. | 898.75M | 2.38% | 47,201 | 16.86M |
| 172 | OMER | Omeros Corporation | 889.80M | -0.55% | 45,077 | - |
| 173 | DRUG | Bright Minds Biosciences Inc. | 880.60M | - | 43 | - |
| 174 | VALN | Valneva SE | 871.34M | 0.95% | 25 | 211.09M |
| 175 | MDXG | MiMedx Group, Inc. | 864.92M | -0.68% | 24,124 | 393.44M |
| 176 | GERN | Geron Corporation | 842.63M | 0.76% | 591,102 | 183.40M |
| 177 | YDES | YD Bio Limited | 836.81M | 0.68% | 520 | 510.36K |
| 178 | JANX | Janux Therapeutics, Inc. | 826.43M | -0.36% | 47,460 | 10.00M |
| 179 | KURA | Kura Oncology, Inc. | 799.69M | -0.22% | 18,888 | 104.03M |
| 180 | ARVN | Arvinas, Inc. | 790.60M | 0.16% | 213,100 | 312.30M |
| 181 | MPLT | MapLight Therapeutics, Inc. | 769.83M | - | 2 | - |
| 182 | RGNX | REGENXBIO Inc. | 757.83M | -0.53% | 38,227 | 161.32M |
| 183 | NKTR | Nektar Therapeutics | 756.10M | 1.61% | 27,739 | 62.60M |
| 184 | KALV | KalVista Pharmaceuticals, Inc. | 755.16M | - | 4,667 | 1.43M |
| 185 | PRME | Prime Medicine, Inc. | 734.71M | -0.24% | 141,474 | 5.98M |
| 186 | ATXS | Astria Therapeutics, Inc. | 715.27M | 0.16% | 15,999 | 706.00K |
| 187 | CTMX | CytomX Therapeutics, Inc. | 708.24M | 2.20% | 61,034 | 113.63M |
| 188 | GYRE | Gyre Therapeutics, Inc. | 708.04M | - | 136 | 107.27M |
| 189 | RIGL | Rigel Pharmaceuticals, Inc. | 700.01M | 1.59% | 11,719 | 282.08M |
| 190 | SLS | SELLAS Life Sciences Group, Inc. | 699.01M | -1.08% | 545,129 | - |
| 191 | DBVT | DBV Technologies S.A. | 694.56M | 0.65% | 12,451 | 5.50M |
| 192 | FULC | Fulcrum Therapeutics, Inc. | 679.49M | 0.49% | 1,709 | 80.00M |
| 193 | PROK | ProKidney Corp. | 674.44M | -2.10% | 16,118 | 744.00K |
| 194 | IVVD | Invivyd, Inc. | 668.31M | 1.28% | 119,335 | 50.04M |
| 195 | EVMN | Evommune, Inc. | 653.18M | -1.05% | 424 | 13.00M |
| 196 | JBIO | Jade Biosciences, Inc. | 634.86M | - | - | - |
| 197 | CGEM | Cullinan Therapeutics, Inc. | 631.53M | -0.37% | 3,568 | - |
| 198 | REPL | Replimune Group, Inc. | 622.06M | -1.37% | 2,436 | - |
| 199 | TENX | Tenax Therapeutics, Inc. | 612.85M | 0.37% | 2,786 | - |
| 200 | GOSS | Gossamer Bio, Inc. | 602.94M | -2.07% | 117,580 | 44.05M |
| 201 | OCGN | Ocugen, Inc. | 594.97M | -0.26% | 821,576 | 5.37M |
| 202 | MGTX | MeiraGTx Holdings plc | 594.83M | 0.14% | 381 | 27.42M |
| 203 | KROS | Keros Therapeutics, Inc. | 594.09M | - | 736 | 246.72M |
| 204 | DRTS | Alpha Tau Medical Ltd. | 581.50M | 3.96% | 59,430 | - |
| 205 | CRMD | CorMedix Inc. | 579.49M | 4.18% | 210,361 | 214.30M |
| 206 | ENGN | enGene Holdings Inc. | 572.72M | 2.03% | 2,877 | - |
| 207 | DSGN | Design Therapeutics, Inc. | 564.35M | 3.52% | 100 | - |
| 208 | FBRX | Forte Biosciences, Inc. | 561.87M | -3.02% | 332,998 | - |
| 209 | LXEO | Lexeo Therapeutics, Inc. | 545.22M | 0.54% | 20,010 | - |
| 210 | VSTM | Verastem, Inc. | 544.13M | -2.08% | 27,202 | 13.38M |
| 211 | DNA | Ginkgo Bioworks Holdings, Inc. | 542.79M | -0.73% | 27,856 | 180.61M |
| 212 | LENZ | LENZ Therapeutics, Inc. | 522.54M | 0.60% | 6,196 | 17.50M |
| 213 | VOR | Vor Biopharma Inc. | 522.34M | - | 97,673 | - |
| 214 | ANRO | Alto Neuroscience, Inc. | 520.98M | 1.64% | 880 | - |
| 215 | NAGE | Niagen Bioscience, Inc. | 513.37M | -1.38% | 41,691 | 124.71M |
| 216 | ABSI | Absci Corporation | 505.25M | 1.51% | 128,001 | 2.82M |
| 217 | LYEL | Lyell Immunopharma, Inc. | 503.69M | - | - | 41.00K |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 502.74M | 1.62% | 4,484 | - |
| 219 | LBRX | LB Pharmaceuticals Inc | 500.67M | - | 513 | - |
| 220 | ASMB | Assembly Biosciences, Inc. | 499.82M | - | 1 | 37.19M |
| 221 | ZVRA | Zevra Therapeutics, Inc. | 498.23M | -0.78% | 18,554 | 84.39M |
| 222 | CRVS | Corvus Pharmaceuticals, Inc. | 493.65M | 1.69% | 108,655 | - |
| 223 | PRTA | Prothena Corporation plc | 480.70M | -0.56% | 8,688 | 11.79M |
| 224 | FDMT | 4D Molecular Therapeutics, Inc. | 468.51M | 4.33% | 27,584 | 120.00K |
| 225 | VTVT | vTv Therapeutics Inc. | 464.96M | 0.40% | 21 | 17.00K |
| 226 | ADCT | ADC Therapeutics SA | 458.35M | - | 444 | 75.21M |
| 227 | IMMP | Immutep Limited | 452.51M | -1.92% | 11,732 | 3.31M |
| 228 | BCYC | Bicycle Therapeutics plc | 450.20M | - | - | 28.34M |
| 229 | MNPR | Monopar Therapeutics Inc. | 444.93M | -0.69% | 15,734 | - |
| 230 | LXRX | Lexicon Pharmaceuticals, Inc. | 439.71M | 0.83% | 2,760 | 70.86M |
| 231 | VNDA | Vanda Pharmaceuticals Inc. | 439.68M | - | 20,682 | 212.07M |
| 232 | DMAC | DiaMedica Therapeutics Inc. | 438.81M | -0.73% | 890 | - |
| 233 | ALT | Altimmune, Inc. | 437.71M | - | 82,330 | 20.00K |
| 234 | PRTC | PureTech Health plc | 432.99M | - | - | 6.39M |
| 235 | AVXL | Anavex Life Sciences Corp. | 427.98M | 3.23% | 117,216 | - |
| 236 | RCKT | Rocket Pharmaceuticals, Inc. | 422.07M | 2.63% | 40,228 | - |
| 237 | EPRX | Eupraxia Pharmaceuticals Inc. | 421.43M | 1.68% | 2,482 | - |
| 238 | BNTC | Benitec Biopharma Inc. | 416.51M | - | 47 | - |
| 239 | NBP | NovaBridge Biosciences | 416.20M | -1.10% | 34,506 | - |
| 240 | SLDB | Solid Biosciences Inc. | 415.65M | 3.39% | 19,431 | - |
| 241 | GLSI | Greenwich LifeSciences, Inc. | 405.66M | 0.90% | 3,033 | - |
| 242 | LCTX | Lineage Cell Therapeutics, Inc. | 403.48M | -0.30% | 70,285 | 10.82M |
| 243 | CTNM | Contineum Therapeutics, Inc. | 398.17M | - | 127 | - |
| 244 | FHTX | Foghorn Therapeutics Inc. | 393.08M | 0.45% | 2,746 | 24.52M |
| 245 | HELP | Cybin Inc. | 390.75M | 1.29% | 15,217 | - |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 378.97M | - | - | 65.32M |
| 247 | TRDA | Entrada Therapeutics, Inc. | 375.11M | - | - | 61.52M |
| 248 | PEPG | PepGen Inc. | 374.68M | -2.68% | 4,444 | - |
| 249 | ALLO | Allogene Therapeutics, Inc. | 373.05M | 1.22% | 83,802 | 22.00K |
| 250 | TECX | Tectonic Therapeutic, Inc. | 369.65M | - | 21 | - |
| 251 | AUTL | Autolus Therapeutics plc | 367.28M | 0.73% | 400,435 | 51.13M |
| 252 | NMRA | Neumora Therapeutics, Inc. | 365.37M | 0.47% | 12,351 | - |
| 253 | ACIU | AC Immune SA | 354.22M | -3.24% | 6,394 | 5.48M |
| 254 | XOMA | XOMA Royalty Corporation | 349.20M | 3.91% | 63,963 | 47.11M |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 338.38M | - | 50 | 33.98M |
| 256 | AARD | Aardvark Therapeutics, Inc. | 334.87M | -0.06% | 120 | - |
| 257 | CADL | Candel Therapeutics, Inc. | 333.23M | -0.98% | 28,050 | - |
| 258 | ZURA | Zura Bio Limited | 331.62M | -1.16% | 1,641 | - |
| 259 | AURA | Aura Biosciences, Inc. | 323.87M | 0.79% | 200 | - |
| 260 | AVTX | Avalo Therapeutics, Inc. | 318.42M | - | 43 | 192.00K |
| 261 | PBYI | Puma Biotechnology, Inc. | 316.96M | 0.80% | 8,318 | 212.00M |
| 262 | CAMP | Camp4 Therapeutics Corporation | 314.40M | - | 3 | 3.80M |
| 263 | CLLS | Cellectis S.A. | 303.85M | -2.35% | 130 | 82.55M |
| 264 | RLMD | Relmada Therapeutics, Inc. | 297.73M | - | 1,708 | - |
| 265 | ACHV | Achieve Life Sciences, Inc. | 297.58M | 1.27% | 9,497 | - |
| 266 | ACRS | Aclaris Therapeutics, Inc. | 293.62M | - | 3,150 | 15.74M |
| 267 | SLN | Silence Therapeutics plc | 279.15M | - | 33 | 25.83M |
| 268 | LRMR | Larimar Therapeutics, Inc. | 279.02M | -2.10% | 109 | - |
| 269 | STTK | Shattuck Labs, Inc. | 277.80M | -2.66% | 196 | 1.00M |
| 270 | PALI | Palisade Bio, Inc. | 277.15M | -1.59% | 125,955 | - |
| 271 | ABEO | Abeona Therapeutics Inc. | 275.29M | -0.20% | 4,119 | 400.00K |
| 272 | GUTS | Fractyl Health, Inc. | 274.09M | -0.50% | 106,371 | 3.00K |
| 273 | AVIR | Atea Pharmaceuticals, Inc. | 273.83M | -0.14% | 4,062 | - |
| 274 | IMRX | Immuneering Corporation | 271.84M | 1.81% | 215,869 | - |
| 275 | HRTX | Heron Therapeutics, Inc. | 269.54M | -0.68% | 2,699 | 155.10M |
| 276 | OABI | OmniAb, Inc. | 269.20M | -1.58% | - | 21.09M |
| 277 | NGNE | Neurogene Inc. | 267.66M | 1.95% | 51 | 925.00K |
| 278 | TARA | Protara Therapeutics, Inc. | 263.11M | -0.20% | 2,404,321 | - |
| 279 | RZLT | Rezolute, Inc. | 261.49M | 13.71% | 343,931 | - |
| 280 | FENC | Fennec Pharmaceuticals Inc. | 258.54M | -0.13% | 20 | 38.79M |
| 281 | MENS | Jyong Biotech Ltd. | 258.38M | -4.00% | 8,778 | - |
| 282 | ALDX | Aldeyra Therapeutics, Inc. | 249.07M | - | 126 | - |
| 283 | OBIO | Orchestra BioMed Holdings, Inc. | 242.23M | 0.23% | 301 | 2.82M |
| 284 | NAUT | Nautilus Biotechnology, Inc. | 239.98M | -3.06% | 300 | - |
| 285 | IMMX | Immix Biopharma, Inc. | 236.08M | -0.88% | 9,067 | - |
| 286 | CCCC | C4 Therapeutics, Inc. | 233.56M | 4.33% | 81,121 | 30.11M |
| 287 | IKT | Inhibikase Therapeutics, Inc. | 231.16M | 0.60% | 8,299 | 1.00 |
| 288 | ENLV | Enlivex Therapeutics Ltd. | 220.76M | 5.13% | 110,955 | - |
| 289 | ZNTL | Zentalis Pharmaceuticals, Inc. | 219.83M | -2.44% | 97,287 | 26.87M |
| 290 | ARMP | Armata Pharmaceuticals, Inc. | 219.17M | -5.20% | 6,092 | 5.05M |
| 291 | VYGR | Voyager Therapeutics, Inc. | 219.06M | -1.99% | 48 | 31.32M |
| 292 | CBIO | Crescent Biopharma, Inc. | 216.02M | - | 65 | - |
| 293 | ARCT | Arcturus Therapeutics Holdings Inc. | 214.53M | -0.26% | 10,450 | 97.60M |
| 294 | HUMA | Humacyte, Inc. | 214.23M | - | 112,242 | 1.57M |
| 295 | NVCT | Nuvectis Pharma, Inc. | 213.88M | 0.48% | - | - |
| 296 | MDWD | MediWound Ltd. | 211.55M | - | 4 | 20.93M |
| 297 | OVID | Ovid Therapeutics Inc. | 211.55M | -1.52% | 20,416 | 6.61M |
| 298 | ALEC | Alector, Inc. | 207.93M | -0.78% | 16,724 | 69.05M |
| 299 | RNAC | Cartesian Therapeutics, Inc. | 207.25M | 4.05% | 3 | 1.09M |
| 300 | CABA | Cabaletta Bio, Inc. | 205.04M | -0.93% | 24,873 | - |
| 301 | EDIT | Editas Medicine, Inc. | 205.00M | 0.48% | 35,411 | 46.38M |
| 302 | CHRS | Coherus Oncology, Inc. | 204.27M | -0.59% | 63,647 | 277.73M |
| 303 | SGMT | Sagimet Biosciences Inc. | 197.63M | -2.14% | 157 | - |
| 304 | MIST | Milestone Pharmaceuticals Inc. | 195.04M | -0.52% | 169,420 | - |
| 305 | GALT | Galectin Therapeutics Inc. | 194.06M | -1.95% | 16,621 | - |
| 306 | CLYM | Climb Bio, Inc. | 193.84M | -1.69% | 14,692 | - |
| 307 | CRDF | Cardiff Oncology, Inc. | 192.99M | -0.17% | 19,532 | 501.00K |
| 308 | TNXP | Tonix Pharmaceuticals Holding Corp. | 191.82M | -0.96% | 10,329 | 10.30M |
| 309 | IPSC | Century Therapeutics, Inc. | 187.72M | - | 35,441 | 113.34M |
| 310 | SABS | SAB Biotherapeutics, Inc. | 187.57M | - | 177 | 114.70K |
| 311 | NTHI | NeOnc Technologies Holdings, Inc. | 186.56M | - | 17 | 59.99K |
| 312 | NERV | Minerva Neurosciences, Inc. | 186.51M | 0.94% | 488 | - |
| 313 | CGEN | Compugen Ltd. | 183.33M | -0.51% | 12,154 | 6.90M |
| 314 | PRLD | Prelude Therapeutics Incorporated | 179.63M | -2.68% | 8,871 | 10.50M |
| 315 | PRQR | ProQR Therapeutics N.V. | 178.03M | 3.05% | 21,877 | 18.86M |
| 316 | SRZN | Surrozen, Inc. | 177.00M | - | 793 | 3.60M |
| 317 | SLGL | Sol-Gel Technologies Ltd. | 175.34M | - | - | 18.97M |
| 318 | KLRS | Kalaris Therapeutics, Inc. | 172.81M | - | - | - |
| 319 | RANI | Rani Therapeutics Holdings, Inc. | 167.70M | -2.82% | 163,887 | 1.20M |
| 320 | QNCX | Quince Therapeutics, Inc. | 165.93M | -1.00% | 59,369 | - |
| 321 | PLX | Protalix BioTherapeutics, Inc. | 164.46M | 1.24% | 21,374 | 61.84M |
| 322 | TNYA | Tenaya Therapeutics, Inc. | 163.40M | -0.57% | 152,775 | - |
| 323 | IPHA | Innate Pharma S.A. | 162.84M | 1.49% | 136 | 14.84M |
| 324 | TLSA | Tiziana Life Sciences Ltd | 159.08M | -0.83% | 111 | - |
| 325 | AGEN | Agenus Inc. | 158.82M | 1.30% | 29,643 | 106.83M |
| 326 | BDTX | Black Diamond Therapeutics, Inc. | 156.68M | - | 123,192 | 70.00M |
| 327 | ELDN | Eledon Pharmaceuticals, Inc. | 155.53M | -0.51% | 33,105 | - |
| 328 | CDXS | Codexis, Inc. | 154.45M | - | 9,938 | 52.93M |
| 329 | MOLN | Molecular Partners AG | 152.15M | -0.97% | 100 | 856.30K |
| 330 | SGMO | Sangamo Therapeutics, Inc. | 151.22M | 0.22% | 193,995 | 32.88M |
| 331 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 149.15M | 1.39% | 430 | - |
| 332 | CRBU | Caribou Biosciences, Inc. | 148.15M | -0.31% | 50,401 | 9.30M |
| 333 | NKTX | Nkarta, Inc. | 145.97M | 0.24% | 17,654 | - |
| 334 | KPTI | Karyopharm Therapeutics Inc. | 144.65M | -0.13% | 2,378 | 142.53M |
| 335 | MCRB | Seres Therapeutics, Inc. | 144.47M | - | 1,350 | 351.00K |
| 336 | TTRX | Turn Therapeutics Inc. | 144.28M | 0.41% | 584 | - |
| 337 | IRD | Opus Genetics, Inc. | 144.14M | -2.34% | 4,564 | 14.63M |
| 338 | CNTX | Context Therapeutics Inc. | 138.74M | 0.67% | 19,879 | - |
| 339 | SPRO | Spero Therapeutics, Inc. | 138.03M | - | 1,505 | 40.55M |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 136.92M | 1.47% | - | 2.00M |
| 341 | ELTX | Elicio Therapeutics, Inc. | 135.78M | - | 654 | - |
| 342 | UNCY | Unicycive Therapeutics, Inc. | 131.10M | 1.16% | 4,109 | - |
| 343 | ACOG | Alpha Cognition Inc. | 130.89M | - | 8 | 7.43M |
| 344 | CGTX | Cognition Therapeutics, Inc. | 130.65M | 3.50% | 25,451 | - |
| 345 | VXRT | Vaxart, Inc. | 128.51M | 1.02% | - | 148.20M |
| 346 | VRCA | Verrica Pharmaceuticals Inc. | 128.24M | - | 204,328 | 30.83M |
| 347 | ACTU | Actuate Therapeutics, Inc. | 126.91M | -1.09% | - | - |
| 348 | WHWK | Whitehawk Therapeutics, Inc. | 125.83M | -2.91% | 5,579 | 14.38M |
| 349 | CNTB | Connect Biopharma Holdings Limited | 121.87M | - | 23 | 762.00K |
| 350 | FATE | Fate Therapeutics, Inc. | 119.97M | 1.96% | 28,656 | 7.14M |
| 351 | GNLX | Genelux Corporation | 118.24M | -2.55% | 11,286 | 8.00K |
| 352 | MREO | Mereo BioPharma Group plc | 117.03M | 11.42% | 5,539,210 | 500.00K |
| 353 | OKYO | OKYO Pharma Limited | 116.97M | - | 40,988 | - |
| 354 | FBIO | Fortress Biotech, Inc. | 116.39M | -3.85% | 192,681 | 62.30M |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 116.11M | 5.62% | 151,927 | 182.34K |
| 356 | PYXS | Pyxis Oncology, Inc. | 113.94M | -2.66% | 147,079 | 2.82M |
| 357 | MGNX | MacroGenics, Inc. | 113.87M | 2.86% | 6,096 | 127.63M |
| 358 | ARTV | Artiva Biotherapeutics, Inc. | 113.15M | 0.22% | 269 | 251.00K |
| 359 | RPTX | Repare Therapeutics Inc. | 111.44M | - | 15,572 | 11.87M |
| 360 | CBUS | Cibus, Inc. | 111.16M | 0.99% | 8,307 | 3.79M |
| 361 | BMEA | Biomea Fusion, Inc. | 110.30M | 2.63% | 74,421 | - |
| 362 | HYFT | MindWalk Holdings Corp. | 108.32M | -4.92% | 106,345 | 19.02M |
| 363 | SEER | Seer, Inc. | 108.00M | 0.52% | 2,882 | 16.38M |
| 364 | ONCY | Oncolytics Biotech Inc. | 107.61M | - | 53,781 | - |
| 365 | ANIX | Anixa Biosciences, Inc. | 106.80M | -2.44% | 6,025 | - |
| 366 | THAR | Tharimmune, Inc. | 105.33M | - | 46,889 | - |
| 367 | ABOS | Acumen Pharmaceuticals, Inc. | 104.79M | - | 298 | - |
| 368 | DTIL | Precision BioSciences, Inc. | 102.30M | 3.41% | 98 | 698.00K |
| 369 | SAVA | Cassava Sciences, Inc. | 100.96M | 1.95% | 34,067 | - |
| 370 | COYA | Coya Therapeutics, Inc. | 98.97M | 2.38% | 29,746 | 3.99M |
| 371 | CSBR | Champions Oncology, Inc. | 97.97M | - | - | 58.42M |
| 372 | ETHZ | ETHZilla Corporation | 96.20M | -1.75% | 25,942 | 4.11M |
| 373 | STRO | Sutro Biopharma, Inc. | 94.31M | 4.14% | 10,983 | 105.65M |
| 374 | VANI | Vivani Medical, Inc. | 93.38M | - | 86,079 | - |
| 375 | SPRB | Spruce Biosciences, Inc. | 87.24M | - | 8 | 697.00K |
| 376 | EXOZ | eXoZymes, Inc. | 85.55M | - | - | -700.00 |
| 377 | KRRO | Korro Bio, Inc. | 84.66M | - | 1,201 | 7.37M |
| 378 | ACET | Adicet Bio, Inc. | 84.49M | 0.84% | 3,644 | - |
| 379 | GANX | Gain Therapeutics, Inc. | 83.85M | -2.24% | 18,436 | - |
| 380 | ANVS | Annovis Bio, Inc. | 82.69M | - | 40,884 | - |
| 381 | ATOS | Atossa Therapeutics, Inc. | 82.02M | -0.11% | 28,177 | - |
| 382 | COEP | Coeptis Therapeutics Holdings, Inc. | 81.68M | - | - | 501.00K |
| 383 | ADAG | Adagene Inc. | 81.07M | 1.18% | 9,357 | 103.20K |
| 384 | PLRX | Pliant Therapeutics, Inc. | 80.50M | 1.55% | 23,339 | - |
| 385 | ALXO | ALX Oncology Holdings Inc. | 80.24M | -0.67% | 1,430 | - |
| 386 | CALC | CalciMedica, Inc. | 79.97M | - | 1,447 | - |
| 387 | IMUX | Immunic, Inc. | 79.80M | -2.05% | 57,456 | - |
| 388 | DWTX | Dogwood Therapeutics, Inc. | 79.37M | - | 2,297 | - |
| 389 | XBIT | XBiotech Inc. | 78.05M | - | 32 | - |
| 390 | PTHS | Pelthos Therapeutics Inc. | 77.83M | - | 19 | 7.41M |
| 391 | PYPD | PolyPid Ltd. | 73.36M | - | 136 | - |
| 392 | IMA | ImageneBio, Inc. | 72.11M | - | 1 | 800.00K |
| 393 | MNOV | MediciNova, Inc. | 70.77M | -0.69% | 4,879 | 257.92K |
| 394 | CRVO | CervoMed Inc. | 69.77M | - | 168 | 6.16M |
| 395 | EQ | Equillium, Inc. | 69.66M | 4.00% | 3,532 | 4.39M |
| 396 | IFRX | InflaRx N.V. | 68.43M | 1.01% | 4,233 | 73.73K |
| 397 | KZIA | Kazia Therapeutics Limited | 68.10M | -0.79% | 10,889 | 1.20M |
| 398 | ATYR | aTyr Pharma, Inc. | 68.00M | -1.71% | 12,168 | 190.00K |
| 399 | BYSI | BeyondSpring Inc. | 67.03M | - | 1,370 | 1.88M |
| 400 | TCRX | TScan Therapeutics, Inc. | 66.96M | 0.85% | 14,258 | 8.42M |
| 401 | ENTX | Entera Bio Ltd. | 66.95M | - | 1,061 | 124.00K |
| 402 | MGX | Metagenomi Therapeutics, Inc. | 64.58M | - | 116 | 30.91M |
| 403 | TVGN | Tevogen Bio Holdings Inc. | 63.58M | 1.98% | 37,717 | - |
| 404 | NRXP | NRx Pharmaceuticals, Inc. | 62.76M | -0.47% | 17,460,032 | 242.00K |
| 405 | PMVP | PMV Pharmaceuticals, Inc. | 61.73M | - | 9 | - |
| 406 | ATHE | Alterity Therapeutics Limited | 61.71M | - | 79 | 3.57M |
| 407 | ANL | Adlai Nortye Ltd. | 60.52M | -0.61% | 706 | -1.35M |
| 408 | ICCC | ImmuCell Corporation | 60.15M | - | - | 27.77M |
| 409 | RADX | Radiopharm Theranostics Limited | 59.15M | -1.16% | 1,812 | 8.20M |
| 410 | MAIA | MAIA Biotechnology, Inc. | 57.40M | -3.23% | 45,369 | - |
| 411 | ALGS | Aligos Therapeutics, Inc. | 56.86M | - | 526 | 2.65M |
| 412 | LPCN | Lipocine Inc. | 56.63M | -2.58% | 459,649 | 4.32M |
| 413 | LITS | Lite Strategy, Inc. | 55.15M | 0.67% | 6,915 | - |
| 414 | INKT | MiNK Therapeutics, Inc. | 54.97M | -0.76% | 105 | - |
| 415 | OSTX | OS Therapies Incorporated | 54.93M | 1.30% | 252,958 | - |
| 416 | GRCE | Grace Therapeutics, Inc. | 54.78M | - | - | - |
| 417 | IBIO | iBio, Inc. | 53.07M | -7.09% | 309,027 | 500.00K |
| 418 | ACRV | Acrivon Therapeutics, Inc. | 53.01M | -1.18% | 58,688 | - |
| 419 | NRXS | NeurAxis, Inc. | 52.84M | 0.81% | 1,272 | 3.36M |
| 420 | PDSB | PDS Biotechnology Corporation | 51.49M | -2.00% | 51,474 | - |
| 421 | NTRB | Nutriband Inc. | 51.18M | -0.71% | 150 | 2.28M |
| 422 | ABVC | ABVC BioPharma, Inc. | 50.68M | 2.38% | - | 797.92K |
| 423 | IBO | Impact BioMedical Inc. | 50.51M | - | 10,570 | 25.00K |
| 424 | TIL | Instil Bio, Inc. | 48.83M | - | 10 | - |
| 425 | PTN | Palatin Technologies, Inc. | 47.18M | -5.52% | 538 | 8.85M |
| 426 | PASG | Passage Bio, Inc. | 46.85M | 3.29% | 115 | - |
| 427 | NXTC | NextCure, Inc. | 46.84M | - | - | - |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 45.73M | - | 3,251 | - |
| 429 | ANEB | Anebulo Pharmaceuticals, Inc. | 45.60M | - | 7,532 | - |
| 430 | KZR | Kezar Life Sciences, Inc. | 45.48M | - | - | - |
| 431 | APLM | Apollomics, Inc. | 44.45M | - | 143 | 6.93M |
| 432 | OKUR | OnKure Therapeutics, Inc. | 44.03M | 3.50% | 157 | - |
| 433 | XLO | Xilio Therapeutics, Inc. | 43.91M | -0.87% | 4,150 | 31.80M |
| 434 | HURA | TuHURA Biosciences, Inc. | 43.17M | -2.27% | 1,069 | - |
| 435 | JSPR | Jasper Therapeutics, Inc. | 43.10M | -1.28% | 30,795 | - |
| 436 | TVRD | Tvardi Therapeutics, Inc. | 42.78M | - | 22 | - |
| 437 | ATNM | Actinium Pharmaceuticals, Inc. | 42.11M | - | 188 | 90.00K |
| 438 | QTTB | Q32 Bio Inc. | 41.65M | 0.45% | 16,324 | - |
| 439 | EVAX | Evaxion A/S | 41.62M | -2.16% | 887 | 7.65M |
| 440 | CVM | CEL-SCI Corporation | 41.20M | -3.54% | 4,729 | - |
| 441 | INMB | INmune Bio, Inc. | 40.14M | 0.67% | 11,198 | 50.00K |
| 442 | CELU | Celularity Inc. | 39.80M | 2.22% | 110 | 40.58M |
| 443 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 39.73M | -4.23% | 434,481 | - |
| 444 | VERU | Veru Inc. | 38.84M | 0.41% | 5,627 | 16.89M |
| 445 | XCUR | Exicure, Inc. | 38.56M | 2.02% | 13,599 | 500.00K |
| 446 | GBIO | Generation Bio Co. | 38.42M | 1.11% | 51,832 | 15.27M |
| 447 | ESLA | Estrella Immunopharma, Inc. | 38.26M | -4.21% | - | - |
| 448 | RNXT | RenovoRx, Inc. | 38.12M | -0.48% | 12,834 | 928.00K |
| 449 | LTRN | Lantern Pharma Inc. | 37.69M | 3.37% | 276 | - |
| 450 | IOBT | IO Biotech, Inc. | 37.38M | 0.50% | 600,176 | - |
| 451 | GLTO | Galecto, Inc. | 37.17M | - | 496 | - |
| 452 | PSTV | Plus Therapeutics, Inc. | 37.02M | -42.69% | 15,281,134 | 5.26M |
| 453 | CING | Cingulate Inc. | 35.70M | 1.02% | 642 | - |
| 454 | OTLK | Outlook Therapeutics, Inc. | 35.32M | -1.87% | 295,095 | 1.41M |
| 455 | ANTX | AN2 Therapeutics, Inc. | 34.53M | - | - | - |
| 456 | JUNS | Jupiter Neurosciences, Inc. | 33.74M | 5.93% | 1,321 | - |
| 457 | GNTA | Genenta Science S.p.A. | 33.04M | -0.70% | 6,049 | - |
| 458 | ATRA | Atara Biotherapeutics, Inc. | 32.34M | 2.63% | 116,720 | 151.93M |
| 459 | SKYE | Skye Bioscience, Inc. | 31.73M | 1.01% | 12,096 | - |
| 460 | DYAI | Dyadic International, Inc. | 31.56M | - | 616 | 3.34M |
| 461 | CUE | Cue Biopharma, Inc. | 31.05M | -2.94% | 1,322 | 7.10M |
| 462 | NRSN | NeuroSense Therapeutics Ltd. | 30.89M | -4.59% | 7,011 | - |
| 463 | BRNS | Barinthus Biotherapeutics plc | 30.83M | -0.58% | 789 | 14.97M |
| 464 | PLUR | Pluri Inc. | 29.86M | - | 1 | 1.33M |
| 465 | RNTX | Rein Therapeutics Inc. | 29.70M | - | 1,619 | - |
| 466 | RLYB | Rallybio Corporation | 29.26M | -1.76% | 591 | 674.00K |
| 467 | LIXT | Lixte Biotechnology Holdings, Inc. | 29.10M | - | 7 | - |
| 468 | HYPD | Hyperion DeFi, Inc. | 28.47M | 2.11% | 18,238 | 345.32K |
| 469 | IGC | IGC Pharma, Inc. | 28.27M | -1.44% | 13,372 | 1.11M |
| 470 | SNTI | Senti Biosciences, Inc. | 27.87M | - | 40,283 | - |
| 471 | BOLD | Boundless Bio, Inc. | 27.76M | - | 141,664 | - |
| 472 | HOWL | Werewolf Therapeutics, Inc. | 27.67M | -0.25% | 50,753 | 1.14M |
| 473 | DARE | Daré Bioscience, Inc. | 27.58M | - | 158 | -57.13K |
| 474 | QNTM | Quantum BioPharma Ltd. | 27.24M | -7.01% | 4,389 | - |
| 475 | MRKR | Marker Therapeutics, Inc. | 27.18M | -4.68% | - | 4.69M |
| 476 | VTGN | Vistagen Therapeutics, Inc. | 26.72M | -1.31% | 69,705 | 721.00K |
| 477 | SER | Serina Therapeutics, Inc. | 26.23M | - | 610 | 116.00K |
| 478 | LONA | LeonaBio, Inc. | 25.79M | - | 102 | - |
| 479 | NNVC | NanoViricides, Inc. | 25.67M | -0.83% | 13,387 | - |
| 480 | INTS | Intensity Therapeutics, Inc. | 24.99M | -0.45% | 225,285 | - |
| 481 | FBLG | FibroBiologics, Inc. | 23.35M | 3.72% | 65,831 | - |
| 482 | KLTO | Klotho Neurosciences, Inc. | 22.49M | -4.82% | 51,421 | - |
| 483 | PLRZ | Polyrizon Ltd. | 22.47M | 1.95% | 6,051 | - |
| 484 | NEUP | Neuphoria Therapeutics Inc. | 21.62M | -3.60% | 251 | 15.65M |
| 485 | LNAI | Lunai Bioworks Inc. | 21.56M | -5.27% | 2,047 | - |
| 486 | CASI | CASI Pharmaceuticals, Inc. | 21.37M | - | - | 26.85M |
| 487 | LIMN | Liminatus Pharma, Inc. | 21.06M | 2.52% | 6,317 | - |
| 488 | CLGN | CollPlant Biotechnologies Ltd. | 20.95M | - | 7 | 2.48M |
| 489 | ALLR | Allarity Therapeutics, Inc. | 20.66M | -1.65% | 5,168 | - |
| 490 | BCTX | BriaCell Therapeutics Corp. | 20.64M | -53.21% | 2,700,939 | - |
| 491 | KTTA | Pasithea Therapeutics Corp. | 20.55M | 1.66% | 2,716 | - |
| 492 | CVKD | Cadrenal Therapeutics, Inc. | 19.80M | -2.31% | 5,668 | - |
| 493 | OSRH | OSR Holdings, Inc. | 19.36M | 1.63% | 303,770 | -90.52K |
| 494 | LSTA | Lisata Therapeutics, Inc. | 18.79M | - | 30 | 1.07M |
| 495 | VYNE | VYNE Therapeutics Inc. | 18.70M | -0.65% | 35,196 | 524.00K |
| 496 | LEXX | Lexaria Bioscience Corp. | 18.67M | -7.29% | 20,069 | 705.92K |
| 497 | BCAB | BioAtla, Inc. | 18.12M | -0.42% | 349,689 | 11.00M |
| 498 | KALA | KALA BIO, Inc. | 17.77M | 3.27% | 30,619 | - |
| 499 | PMN | ProMIS Neurosciences, Inc. | 17.66M | 0.55% | 367 | - |
| 500 | CTXR | Citius Pharmaceuticals, Inc. | 17.41M | -2.17% | 2,949 | - |
| 501 | ITRM | Iterum Therapeutics plc | 17.22M | -3.01% | 1,849 | 390.00K |
| 502 | KAPA | Kairos Pharma, Ltd. | 17.08M | - | 1,640 | - |
| 503 | MTVA | MetaVia Inc. | 17.06M | - | 275 | - |
| 504 | CLRB | Cellectar Biosciences, Inc. | 16.15M | -5.69% | 55,455 | - |
| 505 | HOTH | Hoth Therapeutics, Inc. | 15.99M | -1.87% | 613 | - |
| 506 | APLT | Applied Therapeutics, Inc. | 15.26M | -0.60% | 246,779 | 1.00M |
| 507 | COCP | Cocrystal Pharma, Inc. | 15.16M | 0.92% | 3,427 | - |
| 508 | SNSE | Sensei Biotherapeutics, Inc. | 14.83M | - | 72 | - |
| 509 | BCDA | BioCardia, Inc. | 14.75M | - | 47 | 3.00K |
| 510 | NCNA | NuCana plc | 14.36M | -2.27% | 7,270 | - |
| 511 | SNGX | Soligenix, Inc. | 13.92M | 0.73% | 28,184 | 2.34K |
| 512 | TPST | Tempest Therapeutics, Inc. | 13.87M | 3.12% | 1,166 | - |
| 513 | GDTC | CytoMed Therapeutics Limited | 13.39M | -4.92% | 4,586 | 573.19K |
| 514 | GRDX | GridAI Technologies Corp. | 13.11M | -1.27% | 698 | - |
| 515 | SYBX | Synlogic, Inc. | 13.10M | - | - | 8.00K |
| 516 | MBRX | Moleculin Biotech, Inc. | 12.90M | -2.33% | 12,852 | - |
| 517 | TRAW | Traws Pharma, Inc. | 12.79M | -0.62% | 23,081 | 2.85M |
| 518 | AKTX | Akari Therapeutics, Plc | 12.75M | -0.25% | 11,453 | - |
| 519 | PHIO | Phio Pharmaceuticals Corp. | 12.59M | -0.85% | 3,136 | - |
| 520 | IMNN | Imunon, Inc. | 12.58M | -2.63% | 5,261 | - |
| 521 | AEON | AEON Biopharma, Inc. | 12.55M | -2.75% | 6,015 | - |
| 522 | BLRX | BioLineRx Ltd. | 12.45M | - | 495 | 12.74M |
| 523 | EDSA | Edesa Biotech, Inc. | 12.33M | - | 34,682 | - |
| 524 | BOLT | Bolt Biotherapeutics, Inc. | 12.00M | 4.34% | 10,261 | 5.20M |
| 525 | LGVN | Longeveron Inc. | 11.66M | -0.27% | 11,513 | 1.44M |
| 526 | CRIS | Curis, Inc. | 11.38M | -1.83% | 43,608 | 11.65M |
| 527 | CMMB | Chemomab Therapeutics Ltd. | 11.02M | - | 21 | - |
| 528 | ABP | Abpro Holdings, Inc. | 10.57M | - | - | 183.00K |
| 529 | NCEL | NewcelX Ltd. | 10.53M | -6.48% | 1,895 | - |
| 530 | XTLB | XTL Biopharmaceuticals Ltd. | 10.53M | -16.82% | 562,276 | 968.00K |
| 531 | BRTX | BioRestorative Therapies, Inc. | 10.21M | -2.53% | 1,744 | 383.40K |
| 532 | ICU | SeaStar Medical Holding Corporation | 10.17M | -1.74% | 29,012 | 881.00K |
| 533 | INAB | IN8bio, Inc. | 10.15M | 0.92% | 15,112 | - |
| 534 | ERNA | Ernexa Therapeutics Inc. | 9.65M | -0.81% | 40 | 1,000.00 |
| 535 | EVGN | Evogene Ltd. | 9.45M | 5.83% | 10,025 | 8.02M |
| 536 | BIVI | BioVie Inc. | 9.45M | -1.31% | 4,902 | - |
| 537 | QNRX | Quoin Pharmaceuticals, Ltd. | 9.15M | - | 80 | - |
| 538 | ALZN | Alzamend Neuro, Inc. | 8.97M | -0.42% | 490 | - |
| 539 | PMCB | PharmaCyte Biotech, Inc. | 8.82M | -4.32% | 14,400 | - |
| 540 | APM | Aptorum Group Limited | 8.71M | - | 3,031 | - |
| 541 | IMRN | Immuron Limited | 8.69M | 0.83% | 27,305 | 4.78M |
| 542 | APVO | Aptevo Therapeutics Inc. | 8.56M | -3.38% | 8,222 | - |
| 543 | PULM | Pulmatrix, Inc. | 8.51M | - | - | 3.00K |
| 544 | CLDI | Calidi Biotherapeutics, Inc. | 8.20M | 1.82% | 4,633 | - |
| 545 | KPRX | Kiora Pharmaceuticals, Inc. | 8.03M | - | 50 | 20.00K |
| 546 | ADXN | Addex Therapeutics Ltd | 7.97M | -8.98% | 842 | 198.82K |
| 547 | MBIO | Mustang Bio, Inc. | 7.66M | -3.67% | 9,503 | - |
| 548 | PCSA | Processa Pharmaceuticals, Inc. | 7.48M | 2.48% | 11,707 | - |
| 549 | TOVX | Theriva Biologics, Inc. | 7.39M | -1.75% | 326,274 | - |
| 550 | RNAZ | TransCode Therapeutics, Inc. | 7.34M | -6.32% | 1,448 | - |
| 551 | PPBT | Purple Biotech Ltd | 7.09M | -1.81% | 732 | - |
| 552 | GTBP | GT Biopharma, Inc. | 6.92M | -5.09% | 90,250 | - |
| 553 | BGMS | Bio Green Med Solution, Inc. | 6.81M | - | 1,730 | 81.00K |
| 554 | ASBP | Aspire Biopharma Holdings, Inc. | 6.72M | -21.68% | 24,021,739 | 1.94K |
| 555 | DCOY | Decoy Therapeutics Inc. | 6.64M | -16.80% | 1,117,874 | - |
| 556 | ACXP | Acurx Pharmaceuticals, Inc. | 6.57M | 2.56% | 2,260 | - |
| 557 | SLXN | Silexion Therapeutics Corp | 6.57M | -0.47% | 879 | - |
| 558 | ADIL | Adial Pharmaceuticals, Inc. | 6.39M | 1.81% | 104,872 | - |
| 559 | APRE | Aprea Therapeutics, Inc. | 6.34M | 0.49% | 1,665 | 488.24K |
| 560 | CELZ | Creative Medical Technology Holdings, Inc. | 6.29M | -1.05% | 10,851 | 6.00K |
| 561 | PPCB | Propanc Biopharma, Inc. | 6.01M | 3.81% | 10,624 | - |
| 562 | TCRT | Alaunos Therapeutics, Inc. | 5.85M | - | 1 | 6.00K |
| 563 | GOVX | GeoVax Labs, Inc. | 5.82M | -2.59% | 13,155 | 3.35M |
| 564 | CYCN | Cyclerion Therapeutics, Inc. | 5.79M | -0.65% | 8,883 | 2.86M |
| 565 | CANF | Can-Fite BioPharma Ltd. | 5.61M | -0.24% | 2,980 | 560.00K |
| 566 | VIVS | VivoSim Labs, Inc. | 5.48M | 4.48% | 4,015 | 140.00K |
| 567 | GNPX | Genprex, Inc. | 5.40M | -2.92% | 60,508 | - |
| 568 | REVB | Revelation Biosciences, Inc. | 5.36M | - | 81 | - |
| 569 | INDP | Indaptus Therapeutics, Inc. | 5.25M | -1.64% | 4,449 | - |
| 570 | SILO | Silo Pharma, Inc. | 5.13M | - | 14,792 | 72.10K |
| 571 | XBIO | Xenetic Biosciences, Inc. | 5.04M | -0.45% | 346 | 2.86M |
| 572 | MTNB | Matinas BioPharma Holdings, Inc. | 4.92M | 3.19% | 506 | - |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 4.38M | -3.60% | 11,312 | - |
| 574 | XRTX | XORTX Therapeutics Inc. | 4.16M | 0.84% | 68 | - |
| 575 | CNSP | CNS Pharmaceuticals, Inc. | 3.81M | - | 53 | - |
| 576 | ENVB | Enveric Biosciences, Inc. | 3.76M | -2.39% | 1,107 | - |
| 577 | OGEN | Oragenics, Inc. | 3.71M | 1.23% | 3,138 | - |
| 578 | SPRC | SciSparc Ltd. | 3.67M | -8.57% | 356,368 | 1.31M |
| 579 | PHGE | BiomX Inc. | 3.42M | -1.32% | 509 | - |
| 580 | LYRA | Lyra Therapeutics, Inc. | 3.41M | -3.52% | 1,602 | 600.00K |
| 581 | ENSC | Ensysce Biosciences, Inc. | 3.38M | 0.50% | 6,209 | 4.49M |
| 582 | CMND | Clearmind Medicine Inc. | 3.33M | -9.02% | 911,829 | - |
| 583 | HCWB | HCW Biologics Inc. | 3.24M | - | 54 | 422.03K |
| 584 | GRI | GRI Bio, Inc. | 3.18M | 5.95% | 81,037 | - |
| 585 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.05M | -8.74% | 39,117 | 15.78K |
| 586 | JAGX | Jaguar Health, Inc. | 3.04M | -3.01% | 82,897 | 11.79M |
| 587 | SCNI | Scinai Immunotherapeutics Ltd. | 3.03M | 5.30% | 28,823 | 1.15M |
| 588 | ARTL | Artelo Biosciences, Inc. | 2.97M | -2.65% | 291 | - |
| 589 | BBLG | Bone Biologics Corporation | 2.96M | 1.23% | 1,316 | - |
| 590 | AZTR | Azitra, Inc. | 2.79M | -5.76% | 168,276 | 7.50K |
| 591 | DRMA | Dermata Therapeutics, Inc. | 2.47M | -0.94% | 1,080 | - |
| 592 | CDT | CDT Equity Inc. | 2.42M | -0.71% | 2,249 | - |
| 593 | VRAX | Virax Biolabs Group Limited | 2.40M | 4.29% | 6,145 | 2.99K |
| 594 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.40M | 7.41% | 8,457 | 1.36M |
| 595 | ONCO | Onconetix, Inc. | 2.30M | - | 113 | 1.22M |
| 596 | BDRX | Biodexa Pharmaceuticals Plc | 1.85M | -3.93% | 28,262 | 104.90K |
| 597 | PBM | Psyence Biomedical Ltd. | 1.45M | -1.01% | 14,590 | - |
| 598 | ADTX | Aditxt, Inc. | 1.31M | -1.07% | 19,276 | 5.95K |
| 599 | MLEC | Moolec Science SA | 1.05M | -19.96% | 21,576 | 7.83M |
| 600 | ELAB | PMGC Holdings Inc. | 692.03K | -7.46% | 42,115 | 285.95K |